These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23040422)

  • 61. Isolated post-challenge hyperglycaemia predicts increased cardiovascular mortality.
    Silbernagel G; Sourij H; Grammer TB; Kleber ME; Hartaigh BÓ; Winkelmann BR; Boehm BO; März W
    Atherosclerosis; 2012 Nov; 225(1):194-9. PubMed ID: 22995034
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study.
    Eskesen K; Jensen MT; Galatius S; Vestergaard H; Hildebrandt P; Marott JL; Jensen JS
    J Intern Med; 2013 Jan; 273(1):94-101. PubMed ID: 23009556
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Screening for type 2 diabetes: do screen-detected cases fare better?
    Feldman AL; Griffin SJ; Fhärm E; Norberg M; Wennberg P; Weinehall L; Rolandsson O
    Diabetologia; 2017 Nov; 60(11):2200-2209. PubMed ID: 28831538
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using Health Survey for England data.
    Gordon-Dseagu VL; Mindell JS; Steptoe A; Moody A; Wardle J; Demakakos P; Shelton NJ
    PLoS One; 2015; 10(3):e0119882. PubMed ID: 25785731
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.
    Ridker PM; Pradhan A; MacFadyen JG; Libby P; Glynn RJ
    Lancet; 2012 Aug; 380(9841):565-71. PubMed ID: 22883507
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Glycemic Measures and Risk of Mortality in Older Chinese: The Guangzhou Biobank Cohort Study.
    Jiang CQ; Xu L; Lam TH; Jin YL; Sen Zhang W; Zhu F; Thomas GN; Cheng KK
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31679008
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT.
    Bruce J; Hossain A; Lall R; Withers EJ; Finnegan S; Underwood M; Ji C; Bojke C; Longo R; Hulme C; Hennings S; Sheridan R; Westacott K; Ralhan S; Martin F; Davison J; Shaw F; Skelton DA; Treml J; Willett K; Lamb SE
    Health Technol Assess; 2021 May; 25(34):1-114. PubMed ID: 34075875
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Additional use of glycated hemoglobin for diagnosis of type 2 diabetes in people undergoing coronary angiography reveals a subgroup at increased cardiovascular risk.
    Silbernagel G; Kleber ME; Grammer TB; Winkelmann BR; Boehm BO; März W
    Diabetes Care; 2011 Nov; 34(11):2471-3. PubMed ID: 21911772
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study.
    Pylypchuk R; Wells S; Kerr A; Poppe K; Harwood M; Mehta S; Grey C; Wu BP; Selak V; Drury PL; Chan WC; Orr-Walker B; Murphy R; Mann J; Krebs JD; Zhao J; Jackson R
    Lancet; 2021 Jun; 397(10291):2264-2274. PubMed ID: 34089656
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of a participant-driven health education programme in primary care for people with hyperglycaemia detected by screening: 3-year results from the Ready to Act randomized controlled trial (nested within the ADDITION-Denmark study).
    Maindal HT; Carlsen AH; Lauritzen T; Sandbaek A; Simmons RK
    Diabet Med; 2014 Aug; 31(8):976-86. PubMed ID: 24646371
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial.
    Eborall HC; Griffin SJ; Prevost AT; Kinmonth AL; French DP; Sutton S
    BMJ; 2007 Sep; 335(7618):486. PubMed ID: 17761995
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diabetes screening as part of a vascular disease risk management programme.
    Bartram S; Rigby D
    Community Pract; 2012 Oct; 85(10):24-7. PubMed ID: 23162979
    [TBL] [Abstract][Full Text] [Related]  

  • 73. What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006?
    Cosson E; Nguyen MT; Hamo-Tchatchouang E; Banu I; Chiheb S; Charnaux N; Valensi P
    Diabet Med; 2011 May; 28(5):567-74. PubMed ID: 21480967
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Irish diabetes detection programme in general practice.
    Smith SM; Holohan J; McAuliffe A; Firth RG
    Diabet Med; 2003 Sep; 20(9):717-22. PubMed ID: 12925050
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial.
    Flanagan S; Kunkel J; Appleby V; Eldridge SE; Ismail S; Moreea S; Griffiths C; Walton R; Pitt M; Salmon A; Madurasinghe V; Barnes E; Simms E; Agarwal K; Foster GR
    Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):32-44. PubMed ID: 30477810
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
    Gerstein HC; Colhoun HM; Dagenais GR; Diaz R; Lakshmanan M; Pais P; Probstfield J; Riesmeyer JS; Riddle MC; Rydén L; Xavier D; Atisso CM; Dyal L; Hall S; Rao-Melacini P; Wong G; Avezum A; Basile J; Chung N; Conget I; Cushman WC; Franek E; Hancu N; Hanefeld M; Holt S; Jansky P; Keltai M; Lanas F; Leiter LA; Lopez-Jaramillo P; Cardona Munoz EG; Pirags V; Pogosova N; Raubenheimer PJ; Shaw JE; Sheu WH; Temelkova-Kurktschiev T;
    Lancet; 2019 Jul; 394(10193):121-130. PubMed ID: 31189511
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.
    Bonds DE; Miller ME; Bergenstal RM; Buse JB; Byington RP; Cutler JA; Dudl RJ; Ismail-Beigi F; Kimel AR; Hoogwerf B; Horowitz KR; Savage PJ; Seaquist ER; Simmons DL; Sivitz WI; Speril-Hillen JM; Sweeney ME
    BMJ; 2010 Jan; 340():b4909. PubMed ID: 20061358
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11).
    Landman GW; van Hateren KJ; Kleefstra N; Groenier KH; Gans RO; Bilo HJ
    Br J Gen Pract; 2010 Mar; 60(572):172-5. PubMed ID: 20202363
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study.
    Færch K; Witte DR; Tabák AG; Perreault L; Herder C; Brunner EJ; Kivimäki M; Vistisen D
    Lancet Diabetes Endocrinol; 2013 Sep; 1(1):43-51. PubMed ID: 24622266
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.